• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9552
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Ischemia (1942); Thrombosis/Thrombus (4440)
Event Date 05/29/2022
Event Type  Death  
Event Description
It was reported that stent thrombosis occurred and the patient died.The 90% stenosed target lesion was located in the non tortuous and moderately calcified mid left anterior descending artery.Ticagrelor was given before the percutaneous coronary intervention and during the procedure heparin was administered.A 28 x 2.50 promus premier drug-eluting stent was deployed.However, after stent deployment, blood pressure was low.After the final injection, the patient was sent to the coronary care unit (ccu).After 30 minutes, the pressure started to fall down again and the patient went into cardiac arrest.The physician deemed a stent thrombosis as there was an ischemia noticed through electrocardiogram (ecg) in that area.The patient was treated with direct-current (dc) shock, then continuous cardiopulmonary resuscitation (cpr) was done but the patient didn't revert.The official cause of death was stent thrombosis.
 
Event Description
It was reported that stent thrombosis occurred and the patient died.The 90% stenosed target lesion was located in the non tortuous and moderately calcified mid left anterior descending artery.Ticagrelor was given before the percutaneous coronary intervention and during the procedure heparin was administered.A 28 x 2.50 promus premier drug-eluting stent was deployed.However, after stent deployment, blood pressure was low.After the final injection, the patient was sent to the coronary care unit (ccu).After 30 minutes, the pressure started to fall down again and the patient went into cardiac arrest.The physician deemed a stent thrombosis as there was an ischemia noticed through electrocardiogram (ecg) in that area.The patient was treated with direct-current (dc) shock, then continuous cardiopulmonary resuscitation (cpr) was done but the patient didn't revert.The official cause of death was stent thrombosis.It was further reported that the lesion was predilated with a 2.00x12 mm balloon catheter.The stent was fully deployed and post dilatation was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key14784616
MDR Text Key294563594
Report Number2134265-2022-06363
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeBG
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/15/2023
Device Model Number9552
Device Catalogue Number9552
Device Lot Number0028441476
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/30/2022
Initial Date FDA Received06/23/2022
Supplement Dates Manufacturer Received07/04/2022
Supplement Dates FDA Received07/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-